Kratzer, A., Buchebner, M., Pfeifer, T., Becker, T. M., Uray, G., Miyazaki, M., . . . Kratky, D. (2009). Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemias⃞. Elsevier.
Chicago Style (17th ed.) CitationKratzer, Adelheid, et al. Synthetic LXR Agonist Attenuates Plaque Formation in ApoE-/- Mice Without Inducing Liver Steatosis and Hypertriglyceridemias⃞. Elsevier, 2009.
ציטוט MLAKratzer, Adelheid, et al. Synthetic LXR Agonist Attenuates Plaque Formation in ApoE-/- Mice Without Inducing Liver Steatosis and Hypertriglyceridemias⃞. Elsevier, 2009.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.